Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Norepinephrine release in essential hypertension

G A FitzGerald, V Hossmann, C T Dollery

    Clinical Pharmacology and Therapeutics
    |August 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The Concise Guide to PHARMACOLOGY 2013/14: overview.

    British journal of pharmacology·2014
    Same author

    Intracellular drug concentrations.

    Clinical pharmacology and therapeutics·2013
    Same author

    Acute effects of varying doses of propranolol upon oxygen haemoglobin affinity in man.

    British journal of clinical pharmacology·2012
    Same author

    Metabolism of terbutaline in man and dog.

    British journal of clinical pharmacology·2012
    Same author

    Lapatinib-induced liver injury characterized by class II HLA and Gilbert's syndrome genotypes.

    Clinical pharmacology and therapeutics·2012
    Same author

    Chairman's Introduction.

    Proceedings of the Royal Society of Medicine·2010
    Same journal

    The Future of Clinical Pharmacology: The Right Medicine at the Right Dose for Each Patient.

    Clinical pharmacology and therapeutics·2026
    Same journal

    Effects of Trimethoprim on Three Previously Proposed Putative Biomarkers for OCT2/MATE-Mediated Renal Drug-Drug Interactions in Healthy Volunteers.

    Clinical pharmacology and therapeutics·2026
    Same journal

    Clinical Characterization of Enzyme and Transporter Precipitants to Evaluate Drug-Drug Interactions for Orforglipron, a Small Molecule Glucagon-Like Peptide-1 Receptor Agonist.

    Clinical pharmacology and therapeutics·2026
    Same journal

    Symposium Report: Stakeholders' Perspectives on Phase 1 Trials in Japanese Prior to Multi-Regional Clinical Trials and Future Pathways.

    Clinical pharmacology and therapeutics·2026
    Same journal

    Resolving CYP2D6 Structural Complexity with Long-Read Sequencing: Implications for Tamoxifen Precision Dosing in Thai Breast Cancer Patients.

    Clinical pharmacology and therapeutics·2026
    Same journal

    Identification of a Functional CYP2C8 Variant Allele that Alters Splicing, Reduces Protein Expression, and Increases Drug Exposure.

    Clinical pharmacology and therapeutics·2026
    See all related articles

    Mild essential hypertension is linked to higher norepinephrine levels due to slower clearance, not increased release. Norepinephrine kinetics may explain differences between hypertensive patients and controls.

    Area of Science:

    • Cardiovascular Physiology
    • Neuroendocrinology

    Background:

    • Plasma norepinephrine levels are indicators of sympathetic nervous system activity.
    • Essential hypertension is a complex condition with potential neuroadrenergic contributions.

    Purpose of the Study:

    • To investigate plasma norepinephrine kinetics in newly diagnosed mild essential hypertension.
    • To compare norepinephrine release and clearance between hypertensive patients and normotensive controls.

    Main Methods:

    • Measurement of supine basal plasma norepinephrine.
    • Assessment of sympathetic activation via exercise and postural changes.
    • Determination of norepinephrine clearance and half-life.

    Main Results:

    • Hypertensive patients exhibited higher basal plasma norepinephrine than controls.

    Related Experiment Videos

  • Norepinephrine clearance was slower and half-life longer in hypertensive patients.
  • Neuronal norepinephrine release estimates were similar between groups after kinetic correction.

    • Conclusions:

    • Slower norepinephrine clearance, not increased release, may contribute to elevated plasma norepinephrine in mild essential hypertension.
    • Kinetic variations in norepinephrine handling are significant factors in understanding sympathetic activity differences.